Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin

Haematologica

Volumn 100, Issue 1, 2015, Pages 32-41

  Dorn, Isabel ^a,b   Klich, Katharina ^a,b   Arauzo Bravo, Marcos J ^c,d   Radstaak, Martina ^a   Santourlidis, Simeon ^e   Ghanjati, Foued ^e   Radke, Teja F ^e   Psathaki, Olympia E ^a   Hargus, Gunnar ^a,b   Kramer, Jan ^f,g   Einhaus, Martin ^g   Kim, Jeong Beom ^h   Kögler, Gesine ^e   Wernet, Peter ^e   Schöler, Hans R ^a,i   Schlenke, Peter ^b,j   Zaehres, Holm ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^d BASQUE FOUNDATION FOR SCIENCE   (Spain)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF LÜBECK   (Germany)

^g LADR GmbH   (Germany)

^h Ulsan National Institute of Science and Technology   (South Korea)

ⁱ UNIVERSITY OF MÜNSTER   (Germany)

^j MEDICAL UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; BIOLOGICAL MARKER; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; ERYTHROID CELL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOUSE; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; SKIN FIBROBLAST; COMPARATIVE STUDY; CYTOLOGY; FETUS BLOOD; FIBROBLAST; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

BIOMARKERS; CELL DIFFERENTIATION; DNA METHYLATION; EPIGENOMICS; ERYTHROID CELLS; FETAL BLOOD; FIBROBLASTS; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURAL STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84920111966     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.108068     Document Type: Article

References (50)

1. Giarratana MC, Kobari L, Lapillonne H, Chalmers D, Kiger L, Cynober T, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23(1):69-74.
2. Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol. 2006;24(10):1255-6.
3. + cells by co-culturing with macrophages. Int J Hematol. 2008;87(4):339-50.
4. Zeuner A, Martelli F, Vaglio S, Federici G, Whitsett C, Migliaccio AR. Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion. Stem Cells. 2012;30(8):1587-96.
5. Leberbauer C, Boulmé F, Unfried G, Huber J, Beug H, Müllner EW. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood. 2005;105(1): 85-94.
6. + cells for ex vivo red blood cell production. J Biotechnol. 2009;144(2):127-34.
7. Giarratana MC, Rouard H, Dumont A, Kiger L, Safeukui I, Le Pennec PY, et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood. 2011;118(19):5071-9.
8. Bonig H, Chang KH, Geisen C, Seifried E, Ware C. Blood types of current embryonic stem cell lines are not conducive to culturing "universal-donor" red blood cells. Transfusion. 2008;48(5):1039-40.
9. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-72.
10. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-20.
11. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451(7175):141-6.
12. Zaehres H, Kim JB, Scholer HR. Induced pluripotent stem cells. Methods Enzymol. 2010;476:309-25.
13. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, et al. Generation of induced pluripotent stem cells from human blood. Blood. 2009;113(22):5476-9.
14. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 2008;26(11):1276-84.
15. Kim JB, Greber B, Arauzo-Bravo MJ, Meyer J, Park KI, Zaehres H, et al. Direct reprogramming of human neural stem cells by OCT 4. Nature. 2009; 461(7264): 649-3.
16. Liu H, Ye Z, Kim Y, Sharkis S, Jang YY. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology. 2010;51(5):1810-9.
17. Dias J, Gumenyuk M, Kang H, Vodyanik M, Yu J, Thomson JA, et al. Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev. 2011;20(9):1639-47.
18. Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana MC, Zanella-Cleon I, et al. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica. 2010;95 (10):1651-9.
19. Chang KH, Huang A, Hirata RK, Wang PR, Russell DW, Papayannopoulou T. Globin phenotype of erythroid cells derived from human induced pluripotent stem cells. Blood. 2010;115(12):2553-4.
20. Chang CJ, Mitra K, Koya M, Velho M, Desprat R, Lenz J, et al. Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells. PLoS One. 2011;6(10):e25761.
21. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells. 2010;28(4):704-12.
22. Kobari LI, Yates F, Oudrhiri N, Francina A, Kiger L, Mazurier C, et al. Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model. Haematologica. 2012;97(12):1795-803.
23. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol. 2010;28(8): 848-55.
24. Kim KI, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467(7313):285-90.
25. Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol. 2011;29(12): 1117-9.
26. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature. 2011;471(7336):68-73.
27. Reinhardt P, Schmid B, Burbulla LF, Schöndorf DC, Wagner L, Glatza M, et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell. 2013;12 (3):354-67.
28. Falkenberg H, Radke TF, Kogler G, Stuhler K. Proteomic profiling of ex vivo expanded CD34-positive haematopoetic cells derived from umbilical cord blood. Stem Cells Int. 2013;2013:245695.
29. Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M, et al. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol Ther. 2011;19(4):782-9.
30. Voelkel C, Galla M, Maetzig T, Warlich E, Kuehle J, Zychlinski D, et al. Protein transduction from retroviral Gag precursors. Proc Natl Acad Sci USA. 2010;107(17):7805-10.
31. Zaehres H, Daley GQ. Transgene expression and RNA interference in embryonic stem cells. Methods Enzymol. 2006;420:49-64.
32. Zaehres H, Kogler G, Arauzo-Bravo MJ, Bleidissel M, Santourlidis S, Weinhold S, et al. Induction of pluripotency in human cord blood unrestricted somatic stem cells. Exp Hematol. 2010;38(9):809-18.
33. Cerdan C, Hong SH, Bhatia M. Formation and hematopoietic differentiation of human embryoid bodies by suspension and hanging drop cultures. Current protocols in stem cell biology. 2007;Chapter 1:Unit 1D 2.
34. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004;200(2):123-35.
35. Kieffer NI, Bettaieb A, Legrand C, Coulombel L, Vainchenker W, Edelman L, Breton-Gorius J. Developmentally regulated expression of a 78 kDa erythroblast membrane glycoprotein immunologically related to the platelet thrombospondin receptor. Biochem J. 1989;262(3):835-42.
36. Trowbridge, I.S. "Overview of CD71". In: Schlossman, S.F., et al., editors. Leucocyte Typing V, White Cell Differentiation Antigens. Oxford University Press; 1995: 1139-41.
37. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature. 2008;454(7204):646-50.
38. Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, Mostoslavsky G, et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet. 2009;41(9):968-76.
39. Kleger A, Mahaddalkar PU, Katz SF, Lechel A, Joo JY, Loya K, et al. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex. Gastroenterology. 2012;142(4):907-17.
40. Liang G, Zhang Y. Genetic and epigenetic variations in iPSCs: potential causes and implications for apllication. Cell Stem Cell. 2013;13:149-159.
41. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell. 2011;144(3):439-52.
42. Vodyanik MA, Thomson JA, Slukvin, II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood. 2006;108(6): 2095-105.
43. Qiu C, Hanson E, Olivier E, Inada M, Kaufman DS, Gupta S, et al. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol. 2005;33(12):1450-8.
44. Ye ZI, Liu CF, Lanikova L, Dowey SN, He C, Huang X, et al. Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells. Stem Cells. 2014; 32(1):269-78.
45. Lohle M, Hermann A, Glass H, Kempe A, Schwarz SC, Kim JB, et al. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells. 2012;30(3):570-9.
46. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, et al. Oct4-induced pluripotency in adult neural stem cells. Cell. 2009;136(3):411-9.
47. Huang X, Shah S, Wang J, Ye Z, Dowey SN, Tsang KM, et al. Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors. Mol Ther. 2014; 22(2):451-63.
48. Hirose S, Takayama N, Nakamura S, Nagasawa K, Ochi K, Hirata S, et al. Immortalization of erythroblasts by c-MYC and BCL-XL enables large-scale erythrocyte production from human pluripotent stem cells. Stem Cell Reports. 2013;1(6):499-508.
49. Turker MS. Somatic cell mutations: can they provide a link between aging and cancer? Mech Ageing Dev. 2000;117(1-3):1-19.
50. Gluckman E. Ten years of cord blood transplantation: from bench to bedside. Br J Haematol. 2009;147(2):192-9.